Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
Mallinckrodt
Boehringer Ingelheim
Colorcon

Last Updated: November 26, 2022

CLINICAL TRIALS PROFILE FOR AMITIZA


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Amitiza

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00611442 ↗ Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Completed Takeda N/A 2007-10-01 The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
NCT00611442 ↗ Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Completed Brooke Army Medical Center N/A 2007-10-01 The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
NCT00620061 ↗ Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone Completed Takeda Phase 3 2007-12-01 The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.
NCT00620061 ↗ Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone Completed Sucampo Pharma Americas, LLC Phase 3 2007-12-01 The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.
NCT00620061 ↗ Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone Completed Sucampo Pharmaceuticals, Inc. Phase 3 2007-12-01 The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.
NCT00645801 ↗ Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation Completed Takeda Pharmaceuticals North America, Inc. Phase 4 2008-03-01 The primary objective is to compare the effectiveness and tolerance of Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo and GoLYTELY ® (polyethylene glycol-electrolyte solution) as a bowel cleansing preparation for colonoscopy.
NCT00645801 ↗ Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation Completed Henry Ford Health System Phase 4 2008-03-01 The primary objective is to compare the effectiveness and tolerance of Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo and GoLYTELY ® (polyethylene glycol-electrolyte solution) as a bowel cleansing preparation for colonoscopy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amitiza

Condition Name

Condition Name for Amitiza
Intervention Trials
Constipation 8
Chronic Idiopathic Constipation 5
Irritable Bowel Syndrome 3
Opioid-induced Bowel Dysfunction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Amitiza
Intervention Trials
Constipation 17
Irritable Bowel Syndrome 4
Opioid-Induced Constipation 3
Gastrointestinal Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Amitiza

Trials by Country

Trials by Country for Amitiza
Location Trials
United States 214
United Kingdom 10
Mexico 8
Canada 5
Korea, Republic of 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Amitiza
Location Trials
Texas 14
Alabama 9
Arkansas 8
Georgia 8
Florida 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Amitiza

Clinical Trial Phase

Clinical Trial Phase for Amitiza
Clinical Trial Phase Trials
Phase 4 9
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Amitiza
Clinical Trial Phase Trials
Completed 25
Terminated 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Amitiza

Sponsor Name

Sponsor Name for Amitiza
Sponsor Trials
Takeda 15
Sucampo Pharma Americas, LLC 10
Sucampo AG 8
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Amitiza
Sponsor Trials
Industry 49
Other 18
U.S. Fed 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Express Scripts
McKinsey
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.